EP2872172 - MYCOBACTERIAL ANTIGEN VACCINE [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 20.09.2019 Database last updated on 03.09.2024 | |
Former | The patent has been granted Status updated on 12.10.2018 | ||
Former | Grant of patent is intended Status updated on 05.07.2018 | ||
Former | Examination is in progress Status updated on 17.02.2017 | Most recent event Tooltip | 01.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 03.08.2022 [2022/31] | Applicant(s) | For all designated states Transgene SA Parc d'Innovation Boulevard Gonthier d`Andernach 67400 Illkirch Graffenstaden / FR | [2015/21] | Inventor(s) | 01 /
TUPIN, Emmanuel Fredsborgsgatan 1 117 59 Stockholm / SE | 02 /
MICOL, Romain 11 quai Général Sarrail 69006 Lyon / FR | 03 /
COUPET, Charles Antoine 38 avenue de limburg 69110 Sainte Foy Les Lyon / FR | 04 /
INCHAUPSE, Geneviève 4 rue Villon Les Jardins de l'Europe 69003 Lyon / FR | 05 /
GOUANVIC, Marie 16 rue Lavoisier 69003 Lyon / FR | 06 /
SILVESTRE, Nathalie 6, rue des Iris 67120 Ergersheim / FR | 07 /
MARCHAND, Jean-Baptiste 1A rue des Hauts Pâturages 67210 Obernai / FR | 08 /
BENY, Cécile 14 Chemin des Chênes Le Marchais Rallu 89320 Cerisiers / FR | [2015/21] | Representative(s) | Regimbeau 20, rue de Chazelles 75847 Paris Cedex 17 / FR | [2015/21] | Application number, filing date | 13735275.3 | 10.07.2013 | [2018/46] | WO2013EP64624 | Priority number, date | EP20120305825 | 10.07.2012 Original published format: EP 12305825 | EP20120306539 | 07.12.2012 Original published format: EP 12306539 | EP20130305737 | 03.06.2013 Original published format: EP 13305737 | [2015/21] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2014009438 | Date: | 16.01.2014 | Language: | EN | [2014/03] | Type: | A2 Application without search report | No.: | EP2872172 | Date: | 20.05.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.01.2014 takes the place of the publication of the European patent application. | [2015/21] | Type: | B1 Patent specification | No.: | EP2872172 | Date: | 14.11.2018 | Language: | EN | [2018/46] | Search report(s) | International search report - published on: | EP | 10.04.2014 | Classification | IPC: | A61K39/04 | [2015/21] | CPC: |
A61K39/04 (EP,US);
A61P31/06 (EP);
C07K14/35 (US);
C07K16/1289 (EP,US);
A61K2039/51 (US);
A61K2039/53 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/21] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | IMPFSTOFF MIT EINEM MYKOBAKTERIELLEN ANTIGEN | [2015/21] | English: | MYCOBACTERIAL ANTIGEN VACCINE | [2015/21] | French: | VACCIN ANTIGÉNIQUE MYCOBACTÉRIEN | [2015/21] | Entry into regional phase | 10.02.2015 | National basic fee paid | 10.02.2015 | Designation fee(s) paid | 10.02.2015 | Examination fee paid | Examination procedure | 10.02.2015 | Examination requested [2015/21] | 14.09.2015 | Amendment by applicant (claims and/or description) | 21.02.2017 | Despatch of a communication from the examining division (Time limit: M06) | 03.08.2017 | Reply to a communication from the examining division | 07.06.2018 | Date of oral proceedings | 03.07.2018 | Minutes of oral proceedings despatched | 06.07.2018 | Communication of intention to grant the patent | 28.09.2018 | Fee for grant paid | 28.09.2018 | Fee for publishing/printing paid | 28.09.2018 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 21.02.2017 | Opposition(s) | 15.08.2019 | No opposition filed within time limit [2019/43] | Fees paid | Renewal fee | 06.07.2015 | Renewal fee patent year 03 | 08.07.2016 | Renewal fee patent year 04 | 10.07.2017 | Renewal fee patent year 05 | 11.07.2018 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 10.07.2013 | AL | 14.11.2018 | AT | 14.11.2018 | CY | 14.11.2018 | CZ | 14.11.2018 | DK | 14.11.2018 | EE | 14.11.2018 | ES | 14.11.2018 | FI | 14.11.2018 | HR | 14.11.2018 | IT | 14.11.2018 | LT | 14.11.2018 | LV | 14.11.2018 | MC | 14.11.2018 | MK | 14.11.2018 | MT | 14.11.2018 | PL | 14.11.2018 | RO | 14.11.2018 | RS | 14.11.2018 | SE | 14.11.2018 | SI | 14.11.2018 | SK | 14.11.2018 | SM | 14.11.2018 | TR | 14.11.2018 | BG | 14.02.2019 | NO | 14.02.2019 | GR | 15.02.2019 | IS | 14.03.2019 | PT | 14.03.2019 | LU | 10.07.2019 | BE | 31.07.2019 | [2022/31] |
Former [2021/34] | HU | 10.07.2013 | |
AL | 14.11.2018 | ||
AT | 14.11.2018 | ||
CY | 14.11.2018 | ||
CZ | 14.11.2018 | ||
DK | 14.11.2018 | ||
EE | 14.11.2018 | ||
ES | 14.11.2018 | ||
FI | 14.11.2018 | ||
HR | 14.11.2018 | ||
IT | 14.11.2018 | ||
LT | 14.11.2018 | ||
LV | 14.11.2018 | ||
MC | 14.11.2018 | ||
MT | 14.11.2018 | ||
PL | 14.11.2018 | ||
RO | 14.11.2018 | ||
RS | 14.11.2018 | ||
SE | 14.11.2018 | ||
SI | 14.11.2018 | ||
SK | 14.11.2018 | ||
SM | 14.11.2018 | ||
TR | 14.11.2018 | ||
BG | 14.02.2019 | ||
NO | 14.02.2019 | ||
GR | 15.02.2019 | ||
IS | 14.03.2019 | ||
PT | 14.03.2019 | ||
LU | 10.07.2019 | ||
BE | 31.07.2019 | ||
Former [2021/33] | HU | 10.07.2013 | |
AL | 14.11.2018 | ||
AT | 14.11.2018 | ||
CY | 14.11.2018 | ||
CZ | 14.11.2018 | ||
DK | 14.11.2018 | ||
EE | 14.11.2018 | ||
ES | 14.11.2018 | ||
FI | 14.11.2018 | ||
HR | 14.11.2018 | ||
IT | 14.11.2018 | ||
LT | 14.11.2018 | ||
LV | 14.11.2018 | ||
MC | 14.11.2018 | ||
PL | 14.11.2018 | ||
RO | 14.11.2018 | ||
RS | 14.11.2018 | ||
SE | 14.11.2018 | ||
SI | 14.11.2018 | ||
SK | 14.11.2018 | ||
SM | 14.11.2018 | ||
TR | 14.11.2018 | ||
BG | 14.02.2019 | ||
NO | 14.02.2019 | ||
GR | 15.02.2019 | ||
IS | 14.03.2019 | ||
PT | 14.03.2019 | ||
LU | 10.07.2019 | ||
BE | 31.07.2019 | ||
Former [2021/26] | AL | 14.11.2018 | |
AT | 14.11.2018 | ||
CY | 14.11.2018 | ||
CZ | 14.11.2018 | ||
DK | 14.11.2018 | ||
EE | 14.11.2018 | ||
ES | 14.11.2018 | ||
FI | 14.11.2018 | ||
HR | 14.11.2018 | ||
IT | 14.11.2018 | ||
LT | 14.11.2018 | ||
LV | 14.11.2018 | ||
MC | 14.11.2018 | ||
PL | 14.11.2018 | ||
RO | 14.11.2018 | ||
RS | 14.11.2018 | ||
SE | 14.11.2018 | ||
SI | 14.11.2018 | ||
SK | 14.11.2018 | ||
SM | 14.11.2018 | ||
TR | 14.11.2018 | ||
BG | 14.02.2019 | ||
NO | 14.02.2019 | ||
GR | 15.02.2019 | ||
IS | 14.03.2019 | ||
PT | 14.03.2019 | ||
LU | 10.07.2019 | ||
BE | 31.07.2019 | ||
Former [2021/22] | AL | 14.11.2018 | |
AT | 14.11.2018 | ||
CZ | 14.11.2018 | ||
DK | 14.11.2018 | ||
EE | 14.11.2018 | ||
ES | 14.11.2018 | ||
FI | 14.11.2018 | ||
HR | 14.11.2018 | ||
IT | 14.11.2018 | ||
LT | 14.11.2018 | ||
LV | 14.11.2018 | ||
MC | 14.11.2018 | ||
PL | 14.11.2018 | ||
RO | 14.11.2018 | ||
RS | 14.11.2018 | ||
SE | 14.11.2018 | ||
SI | 14.11.2018 | ||
SK | 14.11.2018 | ||
SM | 14.11.2018 | ||
TR | 14.11.2018 | ||
BG | 14.02.2019 | ||
NO | 14.02.2019 | ||
GR | 15.02.2019 | ||
IS | 14.03.2019 | ||
PT | 14.03.2019 | ||
LU | 10.07.2019 | ||
BE | 31.07.2019 | ||
Former [2020/26] | AL | 14.11.2018 | |
AT | 14.11.2018 | ||
DK | 14.11.2018 | ||
EE | 14.11.2018 | ||
ES | 14.11.2018 | ||
FI | 14.11.2018 | ||
HR | 14.11.2018 | ||
IT | 14.11.2018 | ||
LT | 14.11.2018 | ||
LV | 14.11.2018 | ||
MC | 14.11.2018 | ||
PL | 14.11.2018 | ||
RO | 14.11.2018 | ||
RS | 14.11.2018 | ||
SE | 14.11.2018 | ||
SI | 14.11.2018 | ||
SK | 14.11.2018 | ||
SM | 14.11.2018 | ||
TR | 14.11.2018 | ||
BG | 14.02.2019 | ||
NO | 14.02.2019 | ||
GR | 15.02.2019 | ||
IS | 14.03.2019 | ||
PT | 14.03.2019 | ||
LU | 10.07.2019 | ||
BE | 31.07.2019 | ||
Former [2020/17] | AL | 14.11.2018 | |
AT | 14.11.2018 | ||
DK | 14.11.2018 | ||
EE | 14.11.2018 | ||
ES | 14.11.2018 | ||
FI | 14.11.2018 | ||
HR | 14.11.2018 | ||
IT | 14.11.2018 | ||
LT | 14.11.2018 | ||
LV | 14.11.2018 | ||
MC | 14.11.2018 | ||
PL | 14.11.2018 | ||
RO | 14.11.2018 | ||
RS | 14.11.2018 | ||
SE | 14.11.2018 | ||
SI | 14.11.2018 | ||
SK | 14.11.2018 | ||
SM | 14.11.2018 | ||
TR | 14.11.2018 | ||
BG | 14.02.2019 | ||
NO | 14.02.2019 | ||
GR | 15.02.2019 | ||
IS | 14.03.2019 | ||
PT | 14.03.2019 | ||
Former [2020/14] | AL | 14.11.2018 | |
AT | 14.11.2018 | ||
DK | 14.11.2018 | ||
EE | 14.11.2018 | ||
ES | 14.11.2018 | ||
FI | 14.11.2018 | ||
HR | 14.11.2018 | ||
IT | 14.11.2018 | ||
LT | 14.11.2018 | ||
LV | 14.11.2018 | ||
MC | 14.11.2018 | ||
PL | 14.11.2018 | ||
RO | 14.11.2018 | ||
RS | 14.11.2018 | ||
SE | 14.11.2018 | ||
SI | 14.11.2018 | ||
SK | 14.11.2018 | ||
SM | 14.11.2018 | ||
BG | 14.02.2019 | ||
NO | 14.02.2019 | ||
GR | 15.02.2019 | ||
IS | 14.03.2019 | ||
PT | 14.03.2019 | ||
Former [2019/50] | AL | 14.11.2018 | |
AT | 14.11.2018 | ||
DK | 14.11.2018 | ||
EE | 14.11.2018 | ||
ES | 14.11.2018 | ||
FI | 14.11.2018 | ||
HR | 14.11.2018 | ||
IT | 14.11.2018 | ||
LT | 14.11.2018 | ||
LV | 14.11.2018 | ||
PL | 14.11.2018 | ||
RO | 14.11.2018 | ||
RS | 14.11.2018 | ||
SE | 14.11.2018 | ||
SI | 14.11.2018 | ||
SK | 14.11.2018 | ||
SM | 14.11.2018 | ||
BG | 14.02.2019 | ||
NO | 14.02.2019 | ||
GR | 15.02.2019 | ||
IS | 14.03.2019 | ||
PT | 14.03.2019 | ||
Former [2019/40] | AL | 14.11.2018 | |
AT | 14.11.2018 | ||
DK | 14.11.2018 | ||
EE | 14.11.2018 | ||
ES | 14.11.2018 | ||
FI | 14.11.2018 | ||
HR | 14.11.2018 | ||
IT | 14.11.2018 | ||
LT | 14.11.2018 | ||
LV | 14.11.2018 | ||
PL | 14.11.2018 | ||
RO | 14.11.2018 | ||
RS | 14.11.2018 | ||
SE | 14.11.2018 | ||
SK | 14.11.2018 | ||
SM | 14.11.2018 | ||
BG | 14.02.2019 | ||
NO | 14.02.2019 | ||
GR | 15.02.2019 | ||
IS | 14.03.2019 | ||
PT | 14.03.2019 | ||
Former [2019/37] | AL | 14.11.2018 | |
AT | 14.11.2018 | ||
DK | 14.11.2018 | ||
EE | 14.11.2018 | ||
ES | 14.11.2018 | ||
FI | 14.11.2018 | ||
HR | 14.11.2018 | ||
IT | 14.11.2018 | ||
LT | 14.11.2018 | ||
LV | 14.11.2018 | ||
PL | 14.11.2018 | ||
RO | 14.11.2018 | ||
RS | 14.11.2018 | ||
SE | 14.11.2018 | ||
SM | 14.11.2018 | ||
BG | 14.02.2019 | ||
NO | 14.02.2019 | ||
GR | 15.02.2019 | ||
IS | 14.03.2019 | ||
PT | 14.03.2019 | ||
Former [2019/35] | AL | 14.11.2018 | |
AT | 14.11.2018 | ||
DK | 14.11.2018 | ||
ES | 14.11.2018 | ||
FI | 14.11.2018 | ||
HR | 14.11.2018 | ||
IT | 14.11.2018 | ||
LT | 14.11.2018 | ||
LV | 14.11.2018 | ||
PL | 14.11.2018 | ||
RS | 14.11.2018 | ||
SE | 14.11.2018 | ||
BG | 14.02.2019 | ||
NO | 14.02.2019 | ||
GR | 15.02.2019 | ||
IS | 14.03.2019 | ||
PT | 14.03.2019 | ||
Former [2019/34] | AL | 14.11.2018 | |
AT | 14.11.2018 | ||
DK | 14.11.2018 | ||
ES | 14.11.2018 | ||
FI | 14.11.2018 | ||
HR | 14.11.2018 | ||
IT | 14.11.2018 | ||
LT | 14.11.2018 | ||
LV | 14.11.2018 | ||
RS | 14.11.2018 | ||
SE | 14.11.2018 | ||
BG | 14.02.2019 | ||
NO | 14.02.2019 | ||
GR | 15.02.2019 | ||
IS | 14.03.2019 | ||
PT | 14.03.2019 | ||
Former [2019/26] | AL | 14.11.2018 | |
AT | 14.11.2018 | ||
ES | 14.11.2018 | ||
FI | 14.11.2018 | ||
HR | 14.11.2018 | ||
LT | 14.11.2018 | ||
LV | 14.11.2018 | ||
RS | 14.11.2018 | ||
SE | 14.11.2018 | ||
BG | 14.02.2019 | ||
NO | 14.02.2019 | ||
GR | 15.02.2019 | ||
IS | 14.03.2019 | ||
PT | 14.03.2019 | ||
Former [2019/25] | AT | 14.11.2018 | |
ES | 14.11.2018 | ||
FI | 14.11.2018 | ||
HR | 14.11.2018 | ||
LT | 14.11.2018 | ||
LV | 14.11.2018 | ||
RS | 14.11.2018 | ||
SE | 14.11.2018 | ||
BG | 14.02.2019 | ||
NO | 14.02.2019 | ||
GR | 15.02.2019 | ||
IS | 14.03.2019 | ||
Former [2019/24] | AT | 14.11.2018 | |
ES | 14.11.2018 | ||
FI | 14.11.2018 | ||
HR | 14.11.2018 | ||
LT | 14.11.2018 | ||
LV | 14.11.2018 | ||
SE | 14.11.2018 | ||
BG | 14.02.2019 | ||
NO | 14.02.2019 | ||
GR | 15.02.2019 | ||
IS | 14.03.2019 | ||
Former [2019/23] | AT | 14.11.2018 | |
ES | 14.11.2018 | ||
FI | 14.11.2018 | ||
HR | 14.11.2018 | ||
LT | 14.11.2018 | ||
LV | 14.11.2018 | ||
BG | 14.02.2019 | ||
NO | 14.02.2019 | ||
IS | 14.03.2019 | ||
Former [2019/22] | FI | 14.11.2018 | |
LT | 14.11.2018 | ||
BG | 14.02.2019 | ||
NO | 14.02.2019 | ||
IS | 14.03.2019 | ||
Former [2019/21] | FI | 14.11.2018 | |
LT | 14.11.2018 | ||
NO | 14.02.2019 | ||
IS | 14.03.2019 | ||
Former [2019/20] | LT | 14.11.2018 | |
NO | 14.02.2019 | Cited in | International search | [XI]WO2006136162 (STATENS SERUMINSTITUT [DK], et al) [X] 1-3,13,47 * page 25, line 24 - line 25 * * page 4, line 1 - line 4 * [I] 4-12,21-44; | [XI]WO2009070700 (AERAS GLOBAL TB VACCINE FOUND [US], et al) [X] 1-13,47 * page 22, line 6 - line 12 * * page 26, line 27 - line 28 * [I] 21-44; | [XI]WO2011144951 (HEALTH PROT AGENCY [GB], et al) [X] 1-4,13,47 * page 48, line 16 - page 50, line 19 * [I] 5-12,21-44; | [XI]WO2012057904 (INFECTIOUS DISEASE RES INST [US], et al) [X] 1,2,13,47 * page 42, line 4 - line 31 * * page 29, line 10 - line 31 * [I] 3-12,21-44; | [AD] - BALDWIN S L ET AL, "Intradermal immunization improves protective efficacy of a novel TB vaccine candidate", VACCINE, ELSEVIER LTD, GB, vol. 27, no. 23, doi:10.1016/J.VACCINE.2009.03.018, ISSN 0264-410X, (20090518), pages 3063 - 3071, (20090326), XP026058724 [AD] 1-13,21-44,47 DOI: http://dx.doi.org/10.1016/j.vaccine.2009.03.018 | [A] - HOUGHTON RAYMOND L ET AL, "Use of multiepitope polyproteins in serodiagnosis of active tuberculosis", CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, (20020701), vol. 9, no. 4, doi:10.1128/CDLI.9.4.883-891.2002, ISSN 1071-412X, pages 883 - 891, XP002511611 [A] 1-13,21-44,47 DOI: http://dx.doi.org/10.1128/CDLI.9.4.883-891.2002 | [A] - ANDERSEN ET AL, "Vaccine strategies against latent tuberculosis infection", TRENDS IN MICROBIOLOGY, ELSEVIER SCIENCE LTD., KIDLINGTON, GB, (20070117), vol. 15, no. 1, doi:10.1016/J.TIM.2006.11.008, ISSN 0966-842X, pages 7 - 13, XP005823946 [A] 1-13,21-44,47 DOI: http://dx.doi.org/10.1016/j.tim.2006.11.008 | [A] - CHEN LEI ET AL, "The development and preliminary evaluation of a new Mycobacterium tuberculosis vaccine comprising Ag85b, HspX and CFP-10:ESAT-6 fusion protein with CpG DNA and aluminum hydroxide adjuvants", FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, (201006), vol. 59, no. 1, ISSN 0928-8244, pages 42 - 52, XP002713096 [A] 1-13,21-44,47 DOI: http://dx.doi.org/10.1111/j.1574-695X.2010.00660.x | by applicant | US5168062 | WO9428152 | US5494807 | WO9700326 | WO9702355 | WO9802522 | WO9856415 | WO9903885 | US5972597 | WO0050573 | US6133028 | US6136594 | WO0070071 | WO0242480 | US6440422 | WO03000721 | WO03004520 | WO03008533 | WO03035681 | WO03053463 | WO03076601 | WO2004006952 | WO2004083418 | WO2004097016 | WO2005071093 | US6998252 | WO2006053871 | WO2006072787 | WO2006104389 | WO2007147529 | WO2008124647 | WO2008138649 | WO2009004016 | WO2010130756 | WO2010130753 | WO2010135495 | US2011008872 | WO2011144951 | WO2012001075 | - COLE ET AL., NATURE, (1998), vol. 393, pages 537 - 44 | - EHLERS ET AL., INFECTION, (2009), vol. 37, pages 87 - 95 | - ROOK ET AL., J INFECT DIS, (2007), vol. 196, pages 191 - 8 | - COOPER ET AL., ANNU REV IMMUNOL, (2009), vol. 27, pages 393 - 422 | - OTTENHOFF; KAUFMANN, PLOS, (2012), vol. 8, no. 5, page E1002607 | - GRODE ET AL., J CLIN INVEST, (2005), vol. 115, pages 2472 - 9 | - THAISSA ET AL., YALE J. OF BIOL. AND MEDICINE, (2010), vol. 83, pages 209 - 15 | - ANDERSEN, NATURE, (2007), vol. 5, page 484 | - KAUFMAN, TREND IN IMMUNOLOGY, (2012), vol. 241, pages 1 - 7 | - LANGERMANS ET AL., VACCINE, (2005), vol. 23, pages 2740 - 50 | - DIETRICH ET AL., J. IMMUNOL., (2007), vol. 178, pages 3721 - 30 | - VAN DISSEL ET AL., VACCINE, (2010), vol. 28, pages 3571 - 81 | - VAN DISSEL, VACCINE, (2011), vol. 29, pages 2100 - 9 | - AAGAARD ET AL., PLOS ONE, vol. 4, pages 1 - 8 | - VON ESCHEN ET AL., HUM VACCINE, (2009), vol. 5, pages 475 - 82 | - BALDWIN ET AL., VACCINE, (2009), vol. 27, pages 3063 - 71 | - BERTHOLET ET AL., SCI TRANSL MED, (2010), vol. 2, no. 53, page 53RA74 | - MC SHANE ET AL., NAT MED, (2004), vol. 10, pages 1240 - 4 | - SCRIBA ET AL., EUR J IMMUNOL, (2010), vol. 40, pages 279 - 90 | - RADOSEVIC ET AL., INFECT IMMUNOL, (2007), vol. 75, pages 4105 - 15 | - MAGALHAES ET AL., PLOS ONE, (2008), vol. 3, page E3790 | - ABEL ET AL., AM J RESPIR CRIT CARE MED, (2010), vol. 181, pages 1407 - 17 | - DELOGU ET AL., J INFECT DEVELOPING COUNTRIES, (2009), vol. 3, pages 5 - 15 | - AAGAARD ET AL., NATURE MED, (2011), vol. 17, pages 189 - 94 | - LIN ET AL., J CLIN INVEST, (2012), vol. 122, pages 303 - 14 | - GOONETILLEKE ET AL., J. IMMUNOL., (2003), vol. 171, pages 1602 - 9 | - DAYHOFFED, Atlas of Protein Sequence and Structure, (1981), vol. 3, pages 482 - 9 | - COLE ET AL., NATURE, (1998), vol. 393, page 537 | - BERTHOLET ET AL., J. IMMUNOL., (2008), vol. 181, pages 7948 - 57 | - BERTHOLET, SCI TRANSL MED, (2010), vol. 2, page 53RA74 | - VOSKUIL ET AL., J. EXP MED, (2003), vol. 198, pages 705 - 13 | - LEYTEN ET AL., MICROBES INF., (2006), vol. 8, pages 2052 - 60 | - ROUPIE ET AL., INFECTION AND IMMUNITY, (2007), vol. 75, pages 941 - 9 | - BLACK ET AL., CLIN VACCINE IMMUNOL, (2009), vol. 16, pages 1203 - 12 | - SCHUCK ET AL., PLOS ONE, (2009), vol. 4, page E5590 | - VIPOND ET AL., VACCINE, (2006), vol. 24, pages 6340 - 50 | - VIPOND ET AL., TUBERCULOSIS, (2007), vol. 86, pages 218 - 24 | - BERTHOLET ET AL., SCI TRANSL MED, (2010), vol. 2, page 53RA74 | - MOLLENKOPF ET AL., INFECT IMMUN, (2004), vol. 72, pages 6471 - 9 | - MUKAMOLOVA ET AL., MOL MICROBIOL, (2002), vol. 46, pages 623 - 35 | - YEREMEEV ET AL., INFECTION AND IMMUNITY, (2003), vol. 71, pages 4789 - 94 | - MUKAMOLOVA ET AL., MOL MICROBIOL, (2006), vol. 59, pages 84 - 98 | - TUFARIELLO ET AL., INFECT IMMUN, (2006), vol. 74, pages 2985 - 95 | - BIKETOV ET AL., MMC INFECT DIS, (2007), vol. 7, page 146 | - KANA ET AL., MOL MICROBIOL, (2008), vol. 67, pages 672 - 84 | - KANA ET AL., FEMS IMMUNOL MED MICROBIOL, (2009), vol. 58, pages 39 - 50 | - RUSSEL-GOLDMAN ET AL., INFECT IMMUN, (2008), vol. 76, pages 4269 - 81 | - GUPTA ET AL., MICROBIOL, (2010), vol. 156, pages 2714 - 22 | - COMMANDEUR ET AL., CLIN VACCINE IMMUNOL., (2011), vol. 18, pages 676 - 83 | - CABRERA ET AL., ARCH BIOCHEM BIOPHYS, (2010), vol. 502, pages 23 - 30 | - CHENG ET AL., J. CLIN. INVEST., (2001), vol. 108, page 669 | - CHEN ET AL., CANCER RES., (2000), vol. 60, page 1035 | - RODRIGUEZ ET AL., J. VIROL., (1997), vol. 71, page 8497 | - SIDNEY ET AL., IMMUNITY, (1994), vol. 1, page 751 | - VORDERMEIER ET AL., EUR. J. IMMUNOL., (1992), vol. 22, page 2631 | - PANINA-BORDIGNON ET AL., EUR. J. IMMUNOL., (1989), vol. 19, page 2237 | - DEMOTZ ET AL., EUR. J. IMMUNOL., (1993), vol. 23, page 425 | - ROTHBARD ET AL., INT. IMMUNOL., (1989), vol. 1, page 479 | - SPENCER ET AL., PLOS ONE, (2012), vol. 7, page E33555 | - LUSKY ET AL., J. VIROL, (1998), vol. 72, page 2022 | - ANTOINE ET AL., VIROL., (1998), vol. 244, page 365 | - BRANDLER ET AL., CIMID, (2008), vol. 31, page 271 | - SINGH ET AL., J. VIROL., (1999), vol. 73, no. 6, page 4823 | - GRIFFIN ET AL., FIELD'S IN VIROLOGY, (2001), pages 1401 - 1441 | - SCHWARZ A, AM J DIS CHILD, (1962), vol. 103, page 216 | - ZHANG ET AL., J MED VIROL., (2009), vol. 81, no. 8, page 1477 | - ERBS ET AL., CANCER GENE THER., (2008), vol. 15, page 18 | - CHAKRABARTI ET AL., BIOTECHNIQUES, (1997), vol. 23, pages 1094 - 7 | - HAMMOND ET AL., J. VIROL METHODS, (1997), vol. 66, pages 135 - 8 | - KUMAR; BOYLE, VIROLOGY, (1990), vol. 179, pages 151 - 8 | - BRANDLER; TANGY, CIMID, (2008), vol. 31, page 271 | - GRAHAM ET AL., J. GEN. VIROL., (1997), vol. 36, pages 59 - 72 | - FALLAUX ET AL., HUMAN GENE THER., (1998), vol. 9, pages 1909 - 17 | - A. GENNARO, Remington : The Science and Practice of Pharmacy, LIPPINCOTT, WILLIAMS&WILKINS | - RIBI ET AL., Immunology and Immunopharmacology of Bacterial Endotoxins, PLENUM PUBL. CORP., (1986), pages 407 - 419 | - KRITSCH ET AL., J. CHROMATOGR ANAL. TECHNOL BIOMED LIFE SCI, (2005), vol. 822, page 263 | - RIANO ET AL., TUBERCULOSIS, (2012), vol. 92, pages 148 - 59 | - ASHWIN ET AL., AM J RESP, (2008), vol. 39, pages 503 - 8 | - ACOSTA ET AL., MALAYS J MED, (2011), vol. 18, pages 5 - 12 | - HOUGARDY ET AL., PLOS ONE, (2007), vol. 2, no. 10, page E926 | - RUHWALD ET AL., MICROBES INFECT, (2008), vol. 9, pages 806 - 12 | - BRAUN ET AL., GENE THER., (2000), vol. 7, page 1447 | - FALKNER ET AL., J. VIROL., (1988), vol. 62, pages 1849 - 54 | - STUDIER, "AI medium containing glucose/lactose and antibiotic", PROTEIN EXPR PURIF., (2005), vol. 41, pages 207 - 34 | - HIMOUDI ET AL., J. VIROL., (2002), vol. 76, pages 12735 - 46 | - HARTINGS ET AL., J PHARMACOL TOXICOL METHODS, (2004), vol. 49, pages 39 - 55 | - JAMES ET AL., J APPL MICROBIOL, (2000), vol. 88, pages 669 - 77 | - AAGAARD ET AL., NAT MED, (2011), vol. 17, pages 189 - 194 | - YEREMEEV ET AL., INFECT IMMUN, (2003), vol. 71, pages 4789 - 94 | - KOLILAB ET AL., CLIN VACCINE IMMUNOL, (2010), vol. 17, pages 793 - 801 | - MALIN ET AL., MICROBES INFECT, (2000), vol. 2, pages 1677 - 85 | - MU ET AL., MOL THER, (2009), vol. 17, pages 1093 - 100 | - DIETRICH ET AL., J IMMUNOL, (2005), vol. 174, pages 6332 - 9 | - HAVENGA ET AL., J GEN VIROL, (2006), vol. 87, pages 2135 - 43 | - SHARPE ET AL., J MOL BIOL, (2008), vol. 383, pages 822 - 36 | - BUCHKO ET AL., BACTERIOL, (2006), vol. 188, pages 5993 - 6001 | - RUGGIERO ET AL., J MOL BIOL, (2009), vol. 385, pages 153 - 62 | - COHEN-GONSAUD ET AL., NAT STRUCT MOL BIOL, (2005), vol. 12, pages 270 - 3 | - STRONG ET AL., PROC NATL ACAD SCI, (2006), vol. 103, pages 8060 - 5 |